A Swedish population-based study on the relationship between the SF-36 and health utilities to measure health in hypertension

Blood Pressure

Volumn 12, Issue 4, 2003, Pages 203-210

  Bardage, Carola ^a,b   Isacson, Dag ^b   Ring, Lena ^b,c   Bingefors, Kerstin ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

General population; Health utilities; Health related quality of life; Hypertension; SF 36 health survey

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REGRESSION ANALYSIS; SWEDEN; TIME; VARIANCE;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ASTHMA; BACK INJURIES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEADACHE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; HYPERTENSION; INTERPERSONAL RELATIONS; LINEAR MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; MOTOR ACTIVITY; PAIN MEASUREMENT; PHYSICAL FITNESS; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SWEDEN;

EID: 0142062426     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050310002083     Document Type: Article

References (44)

1. WHO. Hypertension control. Report of a WHO Expert committee. Geneva: Who Technical Report Series 862, 1996.
2. Mancia G, Lanfranchi A, Cattaneo BM, Grassi G. When patients are rendered normotensive. Cardiology 1994; 85 Suppl 1: 58-64.
3. Dimenäs E. The SSA-profile, an instrument for assessment of subjective symptoms among hypertensives. Scand J Prim Health Care 1990; Suppl 1: 27-30.
4. Dimenäs ES, Wiklund IK, Dahlöf CG, Lindvall KG, Olofsson BK, Faire UH. Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives. J Hypertens 1989; 7: 885-90.
5. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 Suppl 3: S217-32.
6. Ware J, Snow K, Kosinski M, Gandek B SF-36 Health Survey manual and interpretation guide. Boston: New England Medical Center, 1993.
7. Brazier J. The Short-Form 36 (SF-36) health survey and its use in pharmacoeconomic evaluation. PharmacoEconomics 1995; 7: 403-15.
8. Torrance GW. Measurements of health state utilities for economical appraisal. J Health Econ 1986; 5: 1-30.
9. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
10. Battersby C, Hartley K, Fletcher A, et al. Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens 1995; 9: 981-6.
11. Bardage C, Isacson DG. Hypertension and health-related quality of life: an epidemiological study in Sweden. J Clin Epidemiol 2001; 54: 172-81.
12. Ferna'ndez-Lo'pez JA, Siegrist J, Herna'ndez-Mei'a R, Broer M, Cueto-Espinar A. Study of quality of life on rural hypertensive patients. Comparison with the general population of the same environment. J Clin Epidemiol 1994; 47: 1373-80.
13. Krousel-Wood M, Re RN. Health status assessment in a hypertension section of an internal medicine clinic. Am J Med Sci 1994; 308: 211-17.
14. Fryback D, Lawrence W, Martin P, Klein R, Klein B. Predicting quality of well being scores from the SF-36. Med Decis Making 1997; 17: 1-9.
15. Revicki D. Relationship between health utility and psychometric health status measures. Med Care 1992; 30: MS274-82.
16. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993; 2: 477-87.
17. Tsevat J, Goldman L, Lamas G, Pfeffer M, Chapin C, Connors K. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991; 29: 1153-9.
18. Tsevat J, Solzan J, Tolan K, et al. Health status and utilities of HIV+ and primary care patients (abstr). Clin Res 1992; 40: 569.
19. Bosch J, Hunink M. The relationship between descriptive valuational quality of life measures in patients with intermittent claudation. Med Decis Making 1996; 16: 217-25.
20. Read LJ, Quinn RJ, Hoefer MA. Measuring overall health: an evaluation of three important approaches. J Chron Dis 1987; 40: 7-21S.
21. Revicki D, Weinstein M, Alderman M, et al. Health utility and health status outcomes of antihypertensive treatment. Annual meeting of the Association for Health Services Research. Washington, DC: Batelle Medical Technology Assessment and Policy Research Center, 1992.
22. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36): Conceptual framework and item selection. Med Care 1992; 30: 473-83.
23. Sullivan M, Karlsson J, Ware J SF-36 Hälsoenkät: Svensk Manual och Tolkningsguide (Swedish Manual and Interpretation Guide). Göteborg: Sahlgrenska University Hospital, 1994.
24. Sullivan M, Karlsson J, Ware JE. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 1349-58.
25. Bleichrodt H, Johannesson M. An experimental test of a theoretical foundation for rating scale valuations. Med Decis Making 1997; 17: 208-16.
26. Johannesson M, Jönsson B, Karlsson G. Outcome measurement in economic evaluation. Health Econ 1996; 5: 279-96.
27. Von Neuman J, Morgenstern O. Theory of games and economic behaviour. Princeton: University Press, 1953.
28. SAS Institute Inc. SAS Procedures Guide for Personal computers. (Version 6, Third edition). Cary, NC: SAS Institute Inc, 1990.
29. Bardage C, Isacson DGL. Self-reported side-effects of antihypertensive drugs: an epidemiological study on prevalence and impact on health-state utility. Blood Press 2000; 9: 328-34.
30. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13: 89-103.
31. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form health Survey (SF-36): II. Psychometric and Clinical test of validity in measuring physical health and mental constructs. Med Care 1993; 31: 247-63.
32. Persson L-O, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey. Evaluation of the clinical validity: results from population studies of elderly and women in Gothenborg. J Clin Epidemiol 1998; 51: 1095-103.
33. Fryback D, Dasbach E, Klein R, et al. Health assessment by SF-36, quality of well-being index and time trade-offs: predicting one measure from another (abstr). Med Decis Making 1992; 12: 348.
34. Froberg DG, Kane RL. Methodology for measuring health-state preferences - III: population and context effects. J Clin Epidemiol 1989; 42: 585-92.
35. Hornberger J, Redelmeier D, Petersen J. Variablility among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45: 505-12.
36. Lalonde L, Clarke AE, Joseph L, Mackenzie T, Grover SA. Comparing the psychometric properties of preference-based and non-preference-based health-related quality of life in coronary heart disease. Qual Life Res 1999; 8: 399-409.
37. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998; 80: 189-94.
38. Lundberg L, Johannesson M, Isacson DGL, Borgquist L. The relationship between health-state utilities and the SF-12 in a general population. Med Decis Making 1999; 19: 128-40.
39. Johannesson M, Pliskin J, Weinstein M. A note on QALYs, time tradeoff, and discounting. Med Decis Making 1994; 14: 188-93.
40. Kaplan R, Bush J. Health-related quality of life measurement for evaluation of research and policy analysis. Health Psychol 1982; 1: 61-80.
41. Torrance G. Multi-attribute utility theory as a method of measuring social preferences for health state in long term care. In: Kane RL, eds. Value in long term care. DC: Lexington Books Health and Company, 1982.
42. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Health Econ 2002; 21: 271-92.
43. Nord E. Cost-value analysis in health care. Making sense out of QALYs. Cambridge: Cambridge University Press, 1999.
44. Weinstein M, Siegel J, Gold M, Kamlet M, Russell L. Recommendations on the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253-8.